Evidence map›Paper›PMID 29628769›Full record

ArticleInfection and drug resistance2018

Antifungal susceptibility testing of vulvovaginal

Maria Khan, Jawad Ahmed, Amina Gul, Aamer Ikram, Farida Khurram Lalani

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Antifungal Drug Efficacy Profiles Against VaginalJournal of clinical medicine · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antifungal Testing of VaginalJournal of fungi (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Role of ERG11 and MDR1 genes in cycloheximide and multidrug resistance in Candida species.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  17. Antifungal and antibiofilm effects of probioticFrontiers in cellular and infection microbiology · 2024
    Article
  18. Antifungal susceptibility pattern ofFrontiers in cellular and infection microbiology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Maria KhanDepartment of Microbiology, Armed Forces Institute of Pathology, National University of Management Sciences, CMH Rawalpindi, Rawalpindi, Pakistan.
Jawad AhmedDepartment of Microbiology, Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.
Amina GulDepartment of Microbiology, Khyber Medical College, Khyber Medical University, Peshawar, Pakistan.
Aamer IkramDepartment of Microbiology, Armed Forces Institute of Pathology, National University of Management Sciences, CMH Rawalpindi, Rawalpindi, Pakistan.
Farida Khurram LalaniDepartment of Microbiology, Armed Forces Institute of Pathology, National University of Management Sciences, CMH Rawalpindi, Rawalpindi, Pakistan.
Armed Forces Institute of Pathology · PKKhyber Medical College · PKKhyber Medical University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVulvovaginal candidiasis (VVC) is considered as a pervasive gynecological problem among women worldwide. Owing to this fact, in the current study, we aimed at assessing the prevalence rate of

methodsThis study was carried out in the tertiary care hospitals of Peshawar during the period of July 1, 2016 to December 31, 2016. The study group included 450 pregnant women in the age group of 17-44 years with symptoms of excessive vaginal discharge, pain and pruritis. In all, 108 pregnant women were culture positive for

resultsOut of 108

conclusionIn this study, frequency of VVC was noted to be high in the second trimester of pregnancy, with the highest frequency of

Indexed as

fluconazoleitraconazoleketoconazolenystatinvoriconazolevulvovaginal candidiasis

Identifiers

PMID29628769
PMCPMC5878663
OpenAlexW2794744873

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.